RYTM
Rhythm Pharmaceuticals, Inc.
NASDAQ · Healthcare · Biotechnology · US
$102.80
−2.00%Forward multiples
Based on analyst estimates
- P/E forward
- —
- P/E 2026E
- —
- P/E 2027E
- —
- P/E 2028E
- 45.97x
- P/S forward
- 17.29x
Trailing multiples
Trailing twelve months
- P/E TTM
- —
- PEG TTM
- —
- Price / book
- 32.57x
- Price / sales
- 29.50x
- Price / cash flow
- -47.33x
Enterprise value
- Enterprise value
- $6.9B
- EV / sales
- 28.61x
- EV / EBITDA
- -37.16x
- EV / EBIT
- -34.22x
- Market cap
- $7.1B
Trailing, forward and enterprise-value multiples for the requested listing · Data as of Jun 1, 2026